Four months into the COVID-19 pandemic, Sweden's prized is nowhere in sight.
作者信息
Orlowski Eric J W, Goldsmith David J A
机构信息
University College London, Department of Anthropology, Faculty of Social and Historical Sciences, London WC1E 6BT, UK.
Retired Physician, London, UK.
出版信息
J R Soc Med. 2020 Aug;113(8):292-298. doi: 10.1177/0141076820945282.
Abstract
摘要
相似文献
1
Four months into the COVID-19 pandemic, Sweden's prized is nowhere in sight.在新冠疫情爆发四个月后，瑞典所珍视的东西却不见踪影。 （原句中“prized ”这里表述不完整，可能影响准确理解，以上是按现有内容尽量准确翻译）
J R Soc Med. 2020 Aug;113(8):292-298. doi: 10.1177/0141076820945282.
2
Has Sweden's controversial covid-19 strategy been successful or not?瑞典备受争议的新冠疫情应对策略是否成功？
BMJ. 2020 Aug 25;370:m3255. doi: 10.1136/bmj.m3255.
3
To achieve "zero covid" we need to include the controlled, careful acquisition of population (herd) immunity.要实现“动态清零”，我们需要纳入可控、审慎地获取群体免疫这一要素。
BMJ. 2020 Sep 9;370:m3487. doi: 10.1136/bmj.m3487.
4
Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?逐步且可控的群体保护方法是遏制新冠疫情的有效策略吗？
Indian Pediatr. 2020 Jun 15;57(6):505-507. doi: 10.1007/s13312-020-1844-4. Epub 2020 May 6.
5
Misleading media coverage of Sweden's response to covid-19.媒体对瑞典应对新冠疫情的报道存在误导。
BMJ. 2020 Aug 3;370:m3031. doi: 10.1136/bmj.m3031.
6
The false promise of herd immunity for COVID-19.新冠病毒群体免疫的虚假承诺。
Nature. 2020 Nov;587(7832):26-28. doi: 10.1038/d41586-020-02948-4.
7
'Closing borders is ridiculous': the epidemiologist behind Sweden's controversial coronavirus strategy.“关闭边境很荒谬”：瑞典有争议的新冠病毒应对策略背后的流行病学家
Nature. 2020 Apr;580(7805):574. doi: 10.1038/d41586-020-01098-x.
8
COVID-19-a very visible pandemic.新冠疫情——一场极具影响力的大流行病。
Lancet. 2020 Aug 8;396(10248):e17. doi: 10.1016/S0140-6736(20)31675-5.
9
COVID-19 Pandemic: Ways Forward.新冠疫情：未来之路
Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr;9(2):59-60. doi: 10.1097/APO.0000000000000283.
10
COVID-19 herd immunity: where are we?COVID-19 群体免疫：我们在哪里？
Nat Rev Immunol. 2020 Oct;20(10):583-584. doi: 10.1038/s41577-020-00451-5.
引用本文的文献
1
Strength and weakness of disease-induced herd immunity in networks.疾病诱导的网络群体免疫的优势与劣势
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2421460122. doi: 10.1073/pnas.2421460122. Epub 2025 Jul 10.
2
Exploring the factors influencing the adult population's reluctance to accept the COVID-19 vaccine in Tehran.探讨影响德黑兰成年人不愿接种 COVID-19 疫苗的因素。
BMC Health Serv Res. 2024 Nov 11;24(1):1374. doi: 10.1186/s12913-024-11880-6.
3
The "Bystander at the Switch" Revisited? Ethical Implications of the Government Strategies Against COVID-19.《对“电车难题”的再审视？政府抗击新冠疫情策略的伦理意蕴》
J Bioeth Inq. 2024 Sep;21(3):501-511. doi: 10.1007/s11673-023-10328-6. Epub 2024 Feb 15.
4
An adaptive testing strategy for efficient utilization of healthcare resources during an epidemic.一种适应疫情期间高效利用医疗资源的自适应测试策略。
J Theor Biol. 2023 Aug 21;571:111555. doi: 10.1016/j.jtbi.2023.111555. Epub 2023 Jun 7.
5
Perception and Acceptance of COVID-19 Vaccine Among Nurses in Jordan.约旦护士对新冠疫苗的认知与接受情况
SAGE Open Nurs. 2023 May 24;9:23779608231177560. doi: 10.1177/23779608231177560. eCollection 2023 Jan-Dec.
6
Genetic determination of regional connectivity in modelling the spread of COVID-19 outbreak for more efficient mitigation strategies.基于遗传因素确定区域连通性，以建模 COVID-19 疫情传播，制定更有效的缓解策略。
Sci Rep. 2023 May 25;13(1):8470. doi: 10.1038/s41598-023-34959-2.
7
Experiences of People with Cardiovascular Disease during COVID-19 in Sweden: A Qualitative Study.瑞典心血管疾病患者在 COVID-19 大流行期间的经历：一项定性研究。
Int J Environ Res Public Health. 2023 Apr 20;20(8):5588. doi: 10.3390/ijerph20085588.
8
Handling Public Well-being During the COVID-19 Crisis: Empirical Study With Representatives From Municipalities in Sweden.新冠疫情危机期间的公共福祉应对：瑞典各市代表的实证研究
JMIR Form Res. 2023 May 12;7:e40669. doi: 10.2196/40669.
9
Analyzing natural herd immunity media discourse in the United Kingdom and the United States.分析英国和美国关于群体自然免疫的媒体话语。
PLOS Glob Public Health. 2022 Jan 12;2(1):e0000078. doi: 10.1371/journal.pgph.0000078. eCollection 2022.
10
The SEIR model incorporating asymptomatic cases, behavioral measures, and lockdowns: Lesson learned from the COVID-19 flow in Sweden.纳入无症状病例、行为措施和封锁措施的SEIR模型：从瑞典的新冠疫情中吸取的教训
Biomed Signal Process Control. 2023 Mar;81:104416. doi: 10.1016/j.bspc.2022.104416. Epub 2022 Nov 21.
本文引用的文献
1
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany.德国超级传播事件中 SARS-CoV2 的感染病死率。
Nat Commun. 2020 Nov 17;11(1):5829. doi: 10.1038/s41467-020-19509-y.
2
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
3
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.瑞士日内瓦抗 SARS-CoV-2 IgG 抗体的血清流行率（SEROCoV-POP）：一项基于人群的研究。
Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11.
4
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.意大利北部一系列 COVID-19 病例的肺脏尸检结果：一项两中心描述性研究。
Lancet Infect Dis. 2020 Oct;20(10):1135-1140. doi: 10.1016/S1473-3099(20)30434-5. Epub 2020 Jun 8.
5
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.恢复期血浆疗法对重症和危及生命的 COVID-19 患者临床改善时间的影响：一项随机临床试验。
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
6
Herd Immunity: Understanding COVID-19.群体免疫：了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
7
Management of acute kidney injury in patients with COVID-19.COVID-19 患者急性肾损伤的管理。
Lancet Respir Med. 2020 Jul;8(7):738-742. doi: 10.1016/S2213-2600(20)30229-0. Epub 2020 May 14.
8
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
9
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
10
Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.群体免疫——评估受影响国家遏制新冠疫情所需的群体免疫水平。
J Infect. 2020 Jun;80(6):e32-e33. doi: 10.1016/j.jinf.2020.03.027. Epub 2020 Mar 21.
Zotero 插件